Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Signifor LAR in recurrent or progressive meningioma
NCT00859040Phase 2Completed
- Start
- Mar 2009
- Primary completion
- Dec 2011
- Countries
- 1
01
Overview
A Phase 2 trial of pasireotide LAR in meningioma. Started Mar 2009; status: completed.
02
Drugs
pasireotide LAR
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT00859040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859040.